VENUE: Hotel Draken, Göteborg

08.30 – REGISTRATION OPENS (COFFEE)

09.00 – 9.25 SCNP GENERAL ASSEMBLY (MEMBERS ONLY)

9:25 – 9.30 SCNP PRESIDENTS’ WELCOME TO SCNP 62nd ANNUAL MEETING

Sophie Erhardt, Professor, Karolinska Institutet, Sweden

Bo Söderpalm, Professor, University of Gothenburg, Sweden

9.30 – 10.15 SCNP 2024 OPENING LECTURE

Moderator: Sophie Erhardt, Professor, Karolinska Institutet, Sweden

• Is bipolar disorder neuroprogressive? Insights into brain structure, cognition, and biomarkers from longitudinal investigations

Mikael Landén, Professor, University of Gothenburg, Sweden

10.15 - 10.45 COFFEE BREAK AND POSTER VIEWING

10.45 – 12.15 Alcohol Use Disorder

Moderator: Bo Söderpalm, Professor, University of Gothenburg, Sweden

• Neurobiological mechanisms of compulsive alcohol use.

Markus Heilig, Professor, Linköping University, Sweden

• The COMB-study; a multicenter RCT on the effects of varenicline and bupropion in alcohol use disorder.

Andrea de Bejczy, M.D., Ph.D., University of Gothenburg, Sweden

• Sodium oxybate: a substitution therapy for alcohol use disorder?

Julien Guiraud, Ph.D., Vergio Consulting

12.15 – 13.30 LUNCH AND POSTER VIEWING

13.30 – 15.00 SCNP YOUNG SCIENTIST SYMPOSIUM

Moderator: Gregers Wegener, Professor, Aarhus University, Denmark

• Speakers selected based on competition.

15:00 – 15:45 COFFEE BREAK AND POSTER VIEWING

15.45 – 16.30 SCNP LECTURE on depression (35’+10 min)

Moderator: Halldora Jonsdottir, Associate Professor, University of Iceland, Iceland

• New treatment options in TRD: hope or hype? 

Andreas Reif, Professor, University Hospital Frankfurt, Germany

16.30 – A short walk to the PADDAN tour (with REFRESHMENTS)

18.30 – Dinner (at Hotel Draken)

VENUE: Hotel Draken, Göteborg

08.30 – 10.00  ADHD

Moderator: Henry Karlsson, Assoc. Prof., University of Turku, Finland

• Real-world effectiveness of ADHD medications in amphetamine dependence and borderline personality disorder

Milja Hartikainen, MD, PhD, Specialist in forensic psychiatry. Niuvanniemi Hospital, Finland

• ADHD drug use in Iceland and hospitalization for new-onset psychosis or mania among adults 

Halldora Jonsdottir, Associate Professor, University of Iceland, Iceland

• ADHD medications and long-term risk of cardiovascular diseases

Le Zhang, Karolinska Institutet, Sweden

10.00 – 10.30 COFFEE BREAK AND POSTER VIEWING

10.30 – 12.00 Depression-session

• Novel trial designs to personalize antidepressant treatment

Daniel Lindqvist, Associate Professor, Lund University, Sweden

• Psilocybin as an antidepressant? Clinical effect and biological correlates

Johan Lundberg, Adjunct Professor, Karolinska Institutet, Sweden

• Psychocotropic medication and the fetal brain

Lars-Henning Pedersen, Professor, Århus University, Denmark

12.00 – 13.15 LUNCH AND POSTER VIEWING

13.15 – 14.00 SCNP LECTURE (35’+10 min)

• Treatment resistance in psychotic disorders: Are patients not responding to medications, or are clinicians not responding to guidelines

Ingrid Melle, Professor, University of Oslo, Norway

14.00 -14.30 COFFEE BREAK AND POSTER VIEWING

14.30 – 16.00 Schizophrenia (4 x 15+5 min)

Moderator: Sophie Erhardt, Professor, Karolinska Institutet, Sweden

• ImmunoPsychiatry – evidence from large-scale studies to detailed clinical studies

Mikael Benros, Professor, University of, Denmark

• Add-on prednisolone vs. placebo in early psychotic disorders: Results of a pilot study.

Erik Johnsen, Professor, University of Bergen, Norway

• Studies of glial cells and synaptic markers in early stages of psychosis and clinical high-risk states

Simon Cervenka, Professor, Uppsala University, Sweden

• Endocannabinoid dysregulation in psychotic disorders

Heikki Laurikainen, MD, PhD, University of Turku, Finland

16:00 CONCLUSION OF MEETING

Sophie Erhardt & Bo Söderpalm